BMRN

BioMarin Pharmaceutical Inc. News Headlines

$82.36
*  
1.80
2.23%
Get BMRN Alerts
*Delayed - data as of Oct. 30, 2014  -  Find a broker to begin trading BMRN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Venture Capitalist Ran Nussbaum Brings Big Finance To Little Biotechs
4/4/2014 8:31:00 AM - Seeking Alpha


BioMarin Pharmaceutical (BMRN) Shares Cross Below 200 DMA
3/27/2014 1:14:57 PM - BNK Invest


BBH, ALKS, BMRN, ISIS: Large Outflows Detected at ETF
3/27/2014 11:37:34 AM - BNK Invest


Good News for Catalyst Pharma - Analyst Blog
3/26/2014 6:30:01 PM - Zacks.com


Avoid Applied Genetic Technologies IPO
3/26/2014 9:58:00 AM - Seeking Alpha


Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook
3/26/2014 1:17:00 AM - Investopedia


Narrower-than-Expected Loss at Catalyst Pharma - Analyst Blog
3/20/2014 9:20:01 AM - Zacks.com


BioMarin Pharmaceutical Larger Than S&P 500 Component Newmont Mining
2/28/2014 5:51:19 PM - BNK Invest


Interesting BMRN Put And Call Options For October 18th
2/26/2014 12:39:59 PM - BNK Invest


Is NPS Pharmaceuticals The Next Alexion?
2/25/2014 9:56:00 AM - Seeking Alpha


BioMarin Rises on Favorable CHMP Opinion - Analyst Blog
2/21/2014 4:05:01 PM - Zacks.com


Strong 2014 Sales Guidance from BioMarin - Analyst Blog
2/19/2014 6:50:01 PM - Zacks.com


Biotech Stock Roundup: Regeneron's Eylea Impresses, Gilead Files for Next HCV Drug - Analyst Blog
2/19/2014 10:27:01 AM - Zacks.com


Rare Early Success Of Ultragenyx Pharmaceuticals Could Continue With Expiration Of Quiet Period
2/18/2014 2:27:00 PM - Seeking Alpha


FDA Clears BioMarin's Vimizim - Analyst Blog
2/18/2014 1:10:01 PM - Zacks.com


BioMarin Bucks Biotech Short Interest Trend (BIIB, BMRN, MDVN)
2/13/2014 10:18:00 AM - Investopedia


UniQure IPO Could Heal What Ails Investors In 2014
2/4/2014 9:55:00 AM - Seeking Alpha


Ultragenyx Pharmaceuticals IPO Likely To Yield Investors Rewards
1/30/2014 9:55:00 AM - Seeking Alpha


BioMarin's Pipeline Encourages - Analyst Blog
1/23/2014 1:10:01 PM - Zacks.com


Biotech Stock Roundup: Sarepta Spikes on Data & Alnylam on Deal - Analyst Blog
1/22/2014 2:01:01 PM - Zacks.com


Cramer's Lightning Round - Stay Long Kinder Morgan Partners (1/21/14)
1/22/2014 6:36:00 AM - Seeking Alpha


Pipeline Progress at BioMarin - Analyst Blog
1/15/2014 7:20:01 PM - Zacks.com


Celgene, Dendreon Lead Short Interest Trend In Biotechs (BMRN, CELG, DNDN)
1/11/2014 11:46:00 AM - Investopedia


Sector Update: Healthcare Shares Flat Pre-Market; Catalyst Pharmaceutical Partners Rises 14% on Joint Study of Firdapse Tablets
1/8/2014 9:56:51 AM - MT Newswires


Sector Update: Healthcare
1/8/2014 9:56:13 AM - MT Newswires